CA1079189A - Immunoassay method utilizing magnetically attractable particles - Google Patents

Immunoassay method utilizing magnetically attractable particles

Info

Publication number
CA1079189A
CA1079189A CA273,631A CA273631A CA1079189A CA 1079189 A CA1079189 A CA 1079189A CA 273631 A CA273631 A CA 273631A CA 1079189 A CA1079189 A CA 1079189A
Authority
CA
Canada
Prior art keywords
conduit
particulate material
reagent
reaction mixture
along
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA273,631A
Other languages
French (fr)
Inventor
Gordon C. Forrest
Ronald F. Jay
John A. Clements
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Technicon Instruments Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technicon Instruments Corp filed Critical Technicon Instruments Corp
Priority to CA330,571A priority Critical patent/CA1080123A/en
Application granted granted Critical
Publication of CA1079189A publication Critical patent/CA1079189A/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/02Magnetic separation acting directly on the substance being separated
    • B03C1/28Magnetic plugs and dipsticks
    • B03C1/288Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/08Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a stream of discrete samples flowing along a tube system, e.g. flow injection analysis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/18Magnetic separation whereby the particles are suspended in a liquid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1009Characterised by arrangements for controlling the aspiration or dispense of liquids
    • G01N2035/1025Fluid level sensing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Abstract

ABSTRACT OF THE DISCLOSURE

Method and apparatus suitable for automatic assay of fluid samples, particularly immunoassays, in which a reaction product of the assay is bound to a magnetically attractable particle and separated from the reaction mixture by use of a magnetic trap. The method and apparatus are of especial use in radioimmunoassays carried out in an automated continuous-flow manner.

Description

10'79189 -- This invention is concerned with a method and apparatus for analysing a fluid sample, particularly but not exclusively for use in immunoassays.
It is known to assay biological fluids such as blood serum or urine to detect and quantify ~he presence therein of antibodies (and similar binding proteins), antigens (and similar substances such as haptens) and antibody-antigen immune complexes. Such procedures are broadly called immunoassays. One common technique in immunoassays is to make use of the binding reaction which takes place between a limited amount of an antibody and two antigens, both antigens being capable of binding with the antibody but being distinguishable, e.g. in that one antigen carries an identifying label. The pro-portion of labelled anti~en which binds with t~e antibody gives an indication of the amount of unlabelled antigen present. Thus, if for example a biological fluid sample containing a specific antigen is mixed ~ith antibody and an amount of labelled antigen, the amount of (unlabelled) antigen in the sample can be detcrmined.
Various labels have been suggested, but the most successful has been a radioactive label and immuno-assays using radioactive labels are called "radioimmuno-assays~' (RIA).
In immunoassay procedures, it is often necessary to separate the reaction product (e.g. the antibody-antigen complex) from the reaction mixture in order for example to determine the amount of labelled antigen in the product (by direct analysis either of the product or of the remaining reaction mixture). It has been suggested 107918g in the prior art that in RIA procedures (in wllich a separation step is essential), the antibody be immobilised on a carrier to facilitate subsequent separation of the reaction product. Thus, in "Continuous Flow Automated Radioimmunoassay Using Anti-bodies~Attached to Red Blood Cells", by S.J. Luner, Analytical Biochemistry, Vol.65 (1975), pages 355_364, it is said that red blood cells may be used for the immobilisation of antibodies in automated RIA techniques using a continuous-flow system.
In "Magnetic Solid-Phase Radioimmunoassay" by L.S. Hersh and S. Yaverbaum, Clinica Chemica Acta, Vol.63 (1975), pages 69-72, antibody is immobilised on magnetic particles and the reaction product separated from the reaction mixture by application of a magnetic field.
This RIA procedure is carried out in a test tube reactor, and ~he supernatant reaction mixture is assayed.
We have now devised a continuous-flow method of effecting immunoassays, and apparatus useful for this purpose, in which magnetic particles are used and by which a series of liquid samples can be successively and automatically assayed by, for example, RIA.
In one aspect, the invention provides a method of analysing a biological fluid for a constituent of interest, which comprises the steps of:
(a) forming a mixture of a sample of the fluid and a solid phase comprising a reagent bound to a ma~netically attractable particulate material;
(b) flowing the mixture along a conduit;
(c) magnetically trapping the solid phase in the conduit 10'~9~.89 to hold the particulate material against flow and thereby to separate the solid phase from the mixture; and (d) determining the constituent of interest in the sample by analysis on the separated solid phase and/or separated mixture.
In another aspect, the invention rotates to a method of immunoassaying a sample, comprising the steps of mixing:
a sample defining a liquid phase, and a reagent combined with a magnetically attractable particulate defining a solid phase, forming the solid phase to have a specific gravity so as to tend to be suspended within the liquid phase upon mixing of the phases, such that separation of the two phases is retarded and reactivity of the sample with the reagent is enhanced;
magnetically separating the liquid and the solid phases following reaction of the sample with the reagent, and measuring a reaction product of the sample and the reagent in the separated solid and/or the liquid phase.
In yet another aspect, the invention provides analysis apparatus which comprises means for flowing reaction mixtures, in turn, along a conduit and on a discrete basis, each of the reaction mixtures comprising a liquid phase including a fluid sample containing a constituent of interest and a solid phase comprising a first reagent bound to magnetically attractable particulate material, reaction taking place in the mixture to form a reaction product, at least, on the particulate material; means along a portion of the conduit for magnetically trapping the particulate material in each of the reaction mixtures, so as to hold the solid phase against flow and separate the solid phase from the flowing liquid phase; and, downstream of the trapping means, means for determining the constituent of interest by selective analysis of the separated solid phase and/or the separated liquid phase.
In the method of the invention, and in the use of the apparatus, a reaction mixture is flowed along a conduit.
The mixture comprises the sample under test which includes the constituent of interest, i.e. the substance which is to be assayed. In the case, for example, of biological fluids such as blood serum, the constituent of interest may, for example, be an antigent, e.g. a peptide hormone, a steroid hormone, a drug or a virus (the term "antigen" is intended to include haptens and other similar substances), an antibody (which term includes other binding substances), or an antibody;

ywl~ 4a -10'79189 antigen complex, or a single protein. The invention is not limited, however, to the assay of biological fluids.
The reaction mixture also includes, as a solid phase, magnetically attractable particulate material which has a reagent bound thereto. This particulate material may itself be a composite material made up of, for example, a matrix containing magnetically attract-able material, with the reagent bound to the particle.
Such a material is itself novel. The magnetically attractable material may be~ for example, iron or magnetic iron oxides, nickel, cobalt or chromium oxide.
Suitably, one or more particles of such a material are embedded in the matrix. The matrix itself may be of a wide variety of materials including many synthetic and natural polymeric materials (e,g, cellulose, cellulose derivatives, agarose, organic polymers). The reagent may be bound directly to the matrix or to another material within the matrix.
The reagent itself is a substance which takes part in a reaction in the reaction mixture, It may react directly with the constituent of interest in the sample, or it may react not directly with the sample but with a second reagent in the mixture. Thus, for example, the reagent on the particulate matter may be an antibody which will react directly with an antigen in the sample under test, or the sample itself may contain an antibody and the reagent react with an antigen added as the second reagent. In the latter case, the second reagent antigen may also react with the antibody in the sample.

mb/'c 10'~'9189 The reagent is bound to the particulate material in such a manner that the reagent is available to react with another substance in the reaction mixture.
Usually, there will be reagent bound to the peripheral surface of the particulate material, but this is not essential pro~ided that the reagent is accessible for reaction. The reagent may thus be wholly within the matrix but in such case, the matrix will be porous to the liquid of the reaction mixture.
The nature of the reagent can vary ~ery widely, depending on the particular analysis to be performed. It may, for example, be an immuno~lobulin, an antigen (e.g.
a virus) or another biological substance. After reaction, it remains bound (as reaction product) to the particulate material and is thus separated with the particulate material from the reaction mixture.
The separation of the particulate material - solid phase from the liquid phase of the reaction mixture is effected in the conduit using a magnetic trap. The reaction mixture flows along the conduit into the region of a localised magnetic field (the magnetic trap), where-upon the solid phase is held by the field whilst the liquid phase flows on.
Preferably, the magnetic field is dis~osed in the conduit substantially transversely of the flowin~
reaction mixture, but t~is is not essential. As t.ill be clear, the strength of the field must be sufficicnt to hold the solid phase against the liquid flow.
After the liquid has passed through tlle trap, the solid phase in the trap in the conduit can be t.-ashed 9~9 by passing a wash liquid through that portion of the conduit. The solid phase remains held in the trap but the particles are exposed to, and washed by, the wash liquid flowing past. It is a highly advantageous pre-ferred feature of the present invention to be able to wash the solid phase "on line" and thus the apparatus of the invention preferably comprises means for passing wash liquid along the conduit.
The wash liquid may be water or any inert fluid or solution, its purpose being to remove from the solid phase remaining traces of the reaction mixture liquid phase. This is particularly important in immuno-assays, such as RIA, where the solid phase is to be assayed for the presence of a label, since in such cases even trace residues of the reaction mixture liquid phase could lead to incorrect assay results.
The magnetic field is preferably pro~ided by at least one magnet means actuable to providl? magnetic field in a portion of the conduit. The (or ench) magnet means may be a permanent magnet which is mo~cable to vary the field from a minimum (when the trap is "de-actuated") to a maximum "when the trap is "actuated"). I~e prefer, however, to use one or more electromagnets. IJpon de-energisation of the electromagnet, it is prefe)~ble to degauss by providing an alternating current, thlls ridding the electromagnet of residual magnetic field. Solid phase in the trap will also be demagnetised by this procedure, thus reducing any tendency to clogging due to magnetic attraction.
The magnetic trap may consist o~ a slngle 10~79i8g magnet means, or two or more such means. ~or many pur-poses, it is preferred to provide two (or morc) magnetic traps, spaced apart along the conduit. This enables an improved washing procedure, for example, to be effected.
Thus, with two traps, the magnet means of each trap are actuable independently of each other, and the solid phase is separated from the liquid phase of the reaction mixture in the first (upstream) trap. It is washed whilst it is held in that trap, and then the trap is de-actuated to release the solid phase into suspension in flowing wash liquid. The particulate matter is carried to the second trap (which is energised) and held against the wash liquid flow. This double wash procedure is particularly effective.
The liquid phase of the reaction mixture passes through the magnetic trap(s) and flows furtllcr along the conduit. Similarly, after washing, the solid phase is released from the trap and passes along the washed con-duit. Preferably, valving means are provided in the conduit for directing the separated solid pllase or liquid phase to the analysis means as required. If the solid phase is to be analysed, the liguid phase of the reaction mixture can be collected in a recei~er or passed to waste.
If the liquid phase is to be measured (possibly together with wash liquid), the solid phase may be passcd to a receiver, and possibly (after treatment) re-used. It will usually be preferable to assay the solid phase because it can be automatically washed (as described above), whereas the liquid phase is likely to be bulky (with the wash liquid) and not so easily hanclled or anal~-~ec~.

The constituent of interest in the sample is determined by analysis of the separated solid or liquid reaction mixture phases. It will be appreciatcd that this determination may involve several analytical and/or calculation steps. Thus, in the case of RIA, analysis of the solid phase by counting the radioactivity, will reveal the amount of radioactive label in the solid phase. From this, and standard curves, it will be possible to deter-mine the amount of constituent of interest in the sample.
It is possible according to the invention to effect further reactions on the separated solid or liquid phase, and to introduce further magnetically attractable particles for a subsequent separation step. This may be desirable, for example, when the reaction mixture contains an enzyme or co-enzyme. In such cases further magnetic traps may be provided in the conduit downstre~ln of the trap(s) for effecting the first separation.
In the method of the invention, and in use of the apparatus, the whole or any part of the reaction mixture may be preformed before it is flowed along the conduit. It is usually preferred, however, to add one or more reagents to the flowing sample (or ~nrtly formed mixturé) in the conduit. Thus, the apparatus preferably includes means for introducing the said particlllate material and/or the second reagent into admixture with the flowing sample (or reaction mixture) in the conduit.
Intermixing of the sample and the reagents will take place in the conduit as the mixture flows (as is described more fully hereinafter).
Whilst we have specifically referred above to 1079~.89 the reagent bound to the particulate material, and to the second reagent, it will be understood that there may also be other reagents present in the reaction mixture.
These other reagents may be added in admixture with the particulate material or second reagent, or they may be pre-mixed with the sample, or they may be added individ-ually to the flowing sample (or reaction mixture) in the conduit. The nature of these reagents (if any are used) will be determined by the nature of the assay being per-formed. The reaction mixture may also contain other sub-` stances such as buffers.
In immunoassays involving binding between, for example, an antibody and an antigen, the second reagent will usually carry an identifying label such as a radio-active atom, a fluorescent group, an enzyme or co-enzyme or a chemiluminescent material. Thus, for example, when the biological fluid sample is to be assayed for an anti-gen, the reagent on the particulate material will be an antibody for binding with the antigen, and the second re-agent will be an antigen capable of binding with the anti-body and which also carries a label. In the alternative, the fluid sample may be assayed for antibody by pro~-iding an antigen on the particulate material and using a labelled antibody as the second reagent. -As will be understood by those skilled in the art, analysis of the separated solid phase or liquid phase for the amount of label present will allow determination of the amount of constituent of interest in the fluid sample.
The particular analysis to be carried out on the separated solid or liquid phases will depend on the assay being effected and (where a labelled reagent is used) on the nature of the label. Thus, the apparatus of the invention may include, for example, means for measuring the radioactivity, the colour or fluorescence of the separated phase or its enzymic activity.
It will be understood that it is not essential in the method of the invention to use a second or any reagent other than that bound to the particulate matter.
Thus, the method (and apparatus) can be used, for example, to separate a particular constituent from a fluid sample (by selectively binding it to the reagent on the par-ticulate material) and then subsequently assaying the separated solid phase, In most immunoassay procedures, however, a second reagent is used (and there may often be other reagents too).
The method and apparatus of the invention may be used in the known continuous-flow type of procedure in which individual segments of reaction mixture are passed along the conduit, separated by an inert fluid segment (e.g. air) and, if desired, a wash liquid seg-ment. This is described in U.S. specification no.
2,797,149 to which reference should be madc for further details. Thus, the apparatus of the invention preferably includes means for passing successive reaCtiOIl mixtures along said conduit separated from each other b~ at least an inert fluid segment of sufficient volume to occlude said conduit and maintain said successive mixtures dis-crete. The apparatus may also include means for intro-ducing inert fluid segments into said conduit to sub-divide li~uid samples or reaction mixtures thcrein.

10'79189 Further, the apparatus preferably includes means for providing a wash liquid segment bet~een successive reaction mixtures flowing in said conduit, each said mixture being separated from adjacent wash liquid seg-ments by at least an inert fluid segment.
When the reaction mixture (or sample) is segmented, and the particulate material and/or the second reagent is to be added to the flowing segments in the conduit, then means are provided for introducing the particulate material (and/or the second reagent) on an intermittent basis so that they merge with successive sample segments in the conduit. Preferably, the inter-mittent introducing means includes means for returning particulate material not admitted to the conduit, to a resel~oir therefor. Preferably, also, the apparatus includes means for introducing buffer solution into said conduit alternately with said particulate material, so as (in use) to maintain the flow along said conduit sub-stantially constant.
It will be appreciated that it is in-portant that any labelled reagent (or other reagent of critical importance in the final determination procedllrc) be added only to the sample or reaction mixture, and not to any wash liquid or other segments in the conduit, since other-wise an incorrect assay may result.
It is convenient, particularly ~hcn sesmented flow is used, to provide in the apparatus upstre.lm of the magnetic trap(s) a sensing means to detect the passage of a reaction mixture along the conduit and to provide means for actuating the magnetic trap to trap the ~079i89 particles in that reaction mixture, in respons~ to the sensing means. Depending on how far upstream of the trap the sensing means is located, a time delay may be needed before actuation.
The particulate matter will preferably have a specific gravity close to that of the liquid phase of the reaction mixture, so that it does not tend to settle out (nor to float to the top) but rather remains in good admixture in suspension. Generally, the particulate matter will have a specific gravity substantially in the range of about 1.4 to 3.2, although values outside this ran~e can be used.
It will be understood that, in the method of the invention (and in use of the apparatus) sufficient time must be allowed after forming the reaction mixture for the desired reaction(s) to take place, bcfore the solid phase is separated from the liquid pllase. To pro-vide this period (commonly called "incubation"), the con-duit may include, for example, an incubation coil.
In one preferred method of the invcntion, the reaction mixture comprises, as second reagent, a pre-determined amount of a substance which reacts with the constituent of interest to form therewith a complex, and wherein the reagent on the particulate material binds either with the complex or with exccss unreacted second reagent, and wherein in step (d) the separated mixture is analysed to determine the constituent of interest in the sample. In this method, the analysis is carried out either for the complex or for the excess unreacted second reagent, as appropriate.

- 13 ~

10'79189 In another method of the invention, antibody in a sample is assàyed using, as the reagent on the particulate material, an antibody and, as the second re-agent, an antigen (labelled) which will bind with both antibodies (both antibodies may be the same).
It will be understood that, in the method of the invention (and in the use of the apparatus), control over the quantities of reagents used is effected as appropriate. Thus, in RIA, using a radioactively labelled second reagent, for example, the amount of second reagent present (or the amount of label) in the reaction mixture will be controlled and known.
The method and apparatus of the in~ention can advantageously be automated. As such they can provide a ~ighly efficient compact unit, especially uscfu] for immunoassays, particularly RIA.
In order that the in~ention may bc more fully understood, one embodiment thereof will now l)c described, by way of example only, with reference to thc accompanying drawings, in which:
FIGURE 1 is a flow diagram of one form of apparatus according to the present invention;
FIGUÆ 2 illustrates the composition of the fluid stream passed along the system of Figlsrc l;
FIGU~E 2A illustrates the t~o-pllasc laminar flow pattern within the fluid samples of ~isurc 2; and FIGURES 3A-3C illustrate the operation of the on-line magnetic traps to effect separation and working of the solid phase.
Referring now to the drawings, there is sho~n a sampler arrangement lO for supplying a scr;es of liquid samples along a compressible pump tube 12. Sampler arrangement lO may be of the type shown and described in U.S. Patent 3,o38,340. Pump tube 12 is incorporated in a peristaltic-type pump 14, of the type described in U.S. Patent 2,935,028 (which also controls tubes 38, 40, 34, 34 ', 30, 30 ', 32, 36, 52, 57, 84 and 80 as herein-after described). Probe 15 is controlled to be immersed alternately in successive sample receptacles 16, and a wash receptacle 18. As the probe 14 aspirates air between immersion into successive sample receptacles 16 and wash reservoir 18, the sample stream directed along pump tube 12 comprises successive samples, each separated from adjacent samples by air-wash liquid-air segments.
Accordingly, simple integrity is maintaincd during flow along the entire system, as hereinafter descri1cd. In addition to sampler lO, a source 20 of antibodies immobilized on the surface of magnetically attractable particles in suspension, an associated sourcc 22 of the buffer solution, a source 24 of a labelled antigcn in solution, and an associated source 26 of buffer, are pro-~ided. The system is operated such that thc solid phase from source 20, appropriately buffered, and t1~e lebelled antigen from source 24, appropriately buffcred, are intro-duced in controlled discrete volumes and proycr phases, to be mixed only with successive samples pumped along pump tube 12 and conduit 28. To this end, pump 1!~ com-prises a plurality of pump tubes, 30, 32, 3~ and 36 having respective inlets in fluid communication with source 20 of the solid phase, source 2~1 of the labclled m7s~ss antigen and the associated buffer sources 22 and 26.
Also~ pump tubes 38 and 40 are provided for periodically injecting air bubbles to segment the fluid streams passed along pump tubes 30 and 34, to provide discrete segments of uniform concentration of the solid phase and maintain a constant flow rate through the system when valves 40 and 42 are operated. Each of the pump tubes 30~ 32~ 34 and 36 has an associated return conduit 30 321 ~34 ~ and 36 ~ ~ respectively, whereby fluid is re-circulated back tr the respective sources 20, 24. 22 and 26. The outlets of pump tubes 30, 32, 34 and 36 are connected to the inlets of three port-two-position valves, 42, 44, 40 and 46. respectively. One outlet of each such valve is connected to the associated return conduit. The remaining outlets of valves 40 and 42, associated with the solid phase, are multipled and connected along a mixing coil 48 to conduit 28 at junction A. Also, the remaining outlets of valves 4~1 nnd 46 are multipled and connected along conduit 50 to conduit 28 at junction B. Additionally, the outlet of pump tube 52 having an inlet exposed to air, is connected to segment the liquid stream along conduit 50 prior to introduction into conduit 28. As peristaltic pump 14 operates con-tinuously, air segments are continuously injected via air pump tubes 38, 40 and 52 so as to achieve both intra-sample segmentation and intra-wash liquid segnlelltation as hereinafter described, whereby effective internal mixing of the individual segments of the flowing stream along conduit 28 is obtained.
Valves 40, 42, 44 and 46 are contro-led by a 10~79189 programmer 152, whiCh iS timed With respect to sampler lO~ SUCh that the buffered labelled-antigen stream along conduit 50, and the buffered solid phase along mixing coil 48, are intrQduced in discrete Yolumes and in pro-per phase at junctionS B and A~ respectively~ to be inter-mixed only With each liquid sample along conduit 28.
During passage of the wash liquid segment (intermediate successive 8amples) along junction A and also along junction B1 valves 42 and 44 are operated to position I, to interconneCt pump tubes 30 and 32 with conduits 30' and 32', respectively~ and recirculate the liquids being passed therealong to their sources. Simultaneously, valYes 40 and 46 are operated to position II, to direct the buffer solution from Sources 22 and 26, respectively~
to junctions~A and B, to maintain constant flow rates along conduit 28. At this time~ air is beins pumped constantly along pump tube 52, whereby air bubbles are periodically injected into conduit 50 to segment the flUid stream therealong and direct it to junction B, to enSUre proper mixing along coil 55. During passagc of a sample along junctions~A and B~ programmer 152 operates valYes 42 and 44 momentarily to poSition II, to introduce controlled discrete Yolumes of the buffered solid phase along mixing coil 48 and of the labelled antigln sUs-penSion along conduit 50 into such sample. A mi~ing coil 55 is provided along conduit 28 and intermediate junctions A and B, to ensure that the labclled antigens are thoroughly mixed and uniformly distributed through-out each liquid sample segment~ prior to introduction of the solid phase at junc~ on A.

10'7~

The suceessive sample segments, co-mixed with the solid phase and labelled antigen to form reaction mixture, are direeted along conduit 28 to an ineubation eoil 54. The eomposition of the stream direeted to the ineubation 54 is illustrated in Figure 2. Eaeh of the segments, or aliquots, of samples S1, S2, ete. inelude eontrolled volumes of the solid phase and labelled antigen; the wash liquid segments (~J) are between sueeessive samples and the successive samples are themselves segmented by air bubbles introduced along pump tube 52. In Figure 2A, the labelled antigen and the solid phase, i.e. antibodies immobilized on masnet-ieally attractable particles, are distributed throughout a sample aliquot and are indieated by "-" and "~", res-pectively. The presenee of air segment immediately pre-eeding and following a liquid segment induces a two-phase laminar flow pattern, whereby the liqujd in such segment is caused to recirculate, as indicated by the arrows in Figure 2A. Such flow pattern results, primarily, from the drag imposed on the moving liquid immediately at the inner surface of conduit 28, and serves to accelerate the mixing of the various componcnts o~ the reaction mixture.
As described, the solid phase comprises mag-netieally attraetable partieles of controlled specific gravity. Preferably, these particles comprise a matrix having one or more small ferromagnetic particles embedded therein. For example, the ferromagnetic particles may be coated with an organic material, e.g. a pol~leric material, or they may be sl1anizcd, to bind ~qth elth~r 10'79~89 an antibody or antigen. For example, suitable coating techniques have been described in the above-identified Hersh and Yaverbaum article and, also, in "The Pro-perties of Magnetic Supports in Rela*ion to Immobilized Enzyme Reactions", P.J. Robinson et al, Biotechnology and Bioengineering,,Vol.XV. (1973) pp. 603-606. The ratio of the respective volumes of the matrix and the magnetic particles is chosen so that the resulting ~pecific gra~;iy approaches that of the liquid phase.
As such, these magnetically attractable particles are carried along by the two-phase laminar flow pattern induced within each sample aliquot and do not tend to settle out, either by gravitation or flotation. It should be appreciated that the specific gravity of the magnetic particles need not be equal to the specific gravity of the liquid phase, but should be such as to avoid settling or flotation of the solid phase during passage through the system. The reduced density of such particles provides for excellent wash charact~ristics, whereby there is substantially no contamination between successive samples. For example, if the particles were to have a specific gravity much higher than that of the liquid phase, they would tend to settle out and collect in the cusp defined at the interface betwecn the sample aliquot and the up-stream air segment along the inner wall surface of conduit 28. Such settling would sub-stantially increase the possibility that such particles could pass under the up-stream air segment, and follow-ing liquid and air segments in the flo-~ing stream to contaminate a following sample. If the spccific gravity - 19 _ 10'79~B9 of the particles is reduced much below that of the sample, the particles separate out by flotation and may possibly pass over the following liquid and air segments to effect contamination. By controlling the specific gravity of the solid phase, so that it is retained and carried within the two-phase laminar flow pattern, con-tamination between successive samples is avoided.
The reaction mixture stream, with the solid phase constantly circulating within the individual sample aliquots, is passed through an incubation coil 54 to enable the reaction to proceed. The output of incubation coil 54 is greatly diluted by buffer directed along conduit 53 and pump tube 57, to inhibit the reaction (i.e. quench the reaction) and faci7itate wash~ng of the solid phase by a dilution process. Tl~e output of incubation coil 54, is directed along co~d;iit 56 to a wash station, identified as 58. Such wasll station pre-ferably includes a first magnetic trap G() and a second magnetic trap 62, arranged with respect to conduit 56 in on-line fashion. Each of the magnetic traps ~0 and 62 are electromagnetic and arranged to direct magnetic flux transversely to the path of the sample stream. Tl-e magnetic traps 60 and 62 are operated in particular timed sequence by programmer 64 controlled by a sample detector 65. Accordingly, sample detector 65 comprises light source 66 and a detector 68 and is located at t~le output of incubation coil 54. Light from source 66 is directed transversely through conduit 56. When a sample passing along conduit 56 intercepts such light, at time t of Figure 2, the reduced output level of a detector 68 10~79189 instructs programmer 64 to energize the magnetic traps 60 and 62 concurrently.
l~hen energized, first magnetic trap 60, in effect, sweeps the solid phase from each of the sample aliquots comprising, for example, sample S1 as sho~ in Figure 2. The intensity of the magnetic fields generated by the first magnetic trap 60 and, also, the second magnetic trap 62, as hereinafter described, are sufficient to ensure that passage of intra-sample air bubbles within sample S do not dislodge or carry away any of the solid phase retained within the wash station 58. Accordingly, the solid phase in each sample, albeit carried by individual aliquots, is accumulated along conduit 56 passing through the first magnetic trap 60. Energization f magnetic trap 62 at time t1 ensures that any solid phase not swept by magnetic trap 60 is rctained. ~lasnetic trap 60 is energized during passage of the entire volume of sample S and, also, during passage of at lf~ast a portion of the following wash liquid segment, i.e. during time interval t1 - t2 shown in Figure 2. Passage of such wash liquid segment through wash station 5~, while the solid phase is packed, serves to removc any super-natant from the magnetic particles. Before t~le entire wash liquid segment has been passed, at time t, pro-grammer 6~ de-energizes magnetic trap 60. Accordingly, the solid phase is caused to be resuspended ~ithin the remaining wash liquid segment. Air bubbles in the ~ash liquid segment, as introduced along pump tubes 52, tend to break-up the solid phase packed by the magnetic trap 60 and accelerate resuspension of the same in tlle ~-ash 1079~89 liquid to ensure complete removal of any liquid phase, i.e. unbound labelled or unlabelled antigens, from the surfaces thereof. As the second magnetic trap 62 is energized, the solid phase is again swept from the ~-ash liquid segment.
In a particularly preferred embodiment o~ the invention, conduit 56 passing through the ~ash arrange-ment 58 is connected to the inlet of a three-port t~-o-position valve 70, the outputs of such valve being connected to a solid-phase scintillation counter l2 (position 1) and waste (position II), respectivel~.
Also, an additional three-port, two position valve 76 is provided, having an inlet connected along conduit 78 to pump tube 80, whose inlet is connected to a source 82 of buffer, and having outlets connected to waste W
(position I) and solid-phase counter 72 (position II).
Valves 70 and 76 are controlled simultaneously by pro-grammer 64. An additional air pump tube 84, l~aving its inlet exposed to air, is connected to conduit 78, so as to periodically introduce air bubbles into the buffer stream flowed along conduit 78. The buffer liquid pumped along tube 78 is used for cleaning the solid-~hase counter 72. As known, the presence of air bubbles along conduit 78 serves to accelerate the cleaning of any residues of a preceding sample within the solid-phase counter. ~'hen the solid phase in magnetic trap arrangement 5~ has been thoroughly washed and prior to the appearance of the ne~t successive sample adjacent the light sourcc 66, at time t3 of Figure 2, magnetic trap 62 is de-ener~ized and valves 70 and 72 are oper~ ed momentarily to position I, 1~79~89 to direct the solid phase, now suspended in wasl~ liquid, to solid-phase counter 72 and the segmented bnffer stream along conduit 78 to waste. At this time, the solid phase is passed through the storage coil 79 of solid-phase counter 72 and its radioactivity measured. Such measure-ments can be recorded, for example, by a print-out recorder 80. Subsequently, valves 70 and 72 are operated to position II, to direct the fluid stream along conduit 58 to waste and the segmented buffer stream along conduit 78 through the solid-phase counter, preparatory to the washing and measurement of the solid-phase in a next sample.
It will be evid~ent that the liquid-phase can be measured, if desired, rather than the solid phase. To this end, a liquid-phase scintillation counter could be substituted for the solid-phase counter 74. In such event, the magnetic traps 60 and 62 are operated, as described, to sweep out the solid-phase from t}lc aliquots of the same ~ample. Concurrently, valves 70 ~nd 72 are controlled (to position I) to pass the separntcd liquid phase directly to the storage coil of the liqu-id-phase counter and while magnetic traps 60 and 62 are cnergized.
Subsequently, valves 70 and 72 are operated to position II, prior to de-energization o~ magnetic traps 60 and 62, such that the solid-phase re-suspended in the ~;ash liquid is passed to waste and the segmented buffcr l;~uid is passed to wash the liquid-phase counter. In ei1ller e~rent, it can be appreciated that the controlled specific gravity of the magnetic particles, on which the solid phase is immobilized, and the magnetic in-line trappiIig techniqlle described, co-operate to achieve a positive ~ep~ration of the solid and liquid phases, without deteriorating the wash characteristics of the system.
In accordance with another aspect of the invention, (not illustrated) the individual samples passed along the conduit 28 may be reacted selectively.
For example, we can provide a plurality of solid phase sources 20 and label sources 24, each having an assoc-iated pump tube 30 and return conduit 30', each of which can be connected to a respective three part, two-position changeover valve. The outputs of the change-over valves for each of the solid phase and label systems as well as the outputs of the buffer valves may be connected to corresponding inlets of a multi input/single output valve, whose output is connected to junctions A and B.
Each of the single output valves is controlled in response to information read from the individual receptacle 16, so as to introduce $he appropriate solid phase and label phase, in phase with each otller, at junctions B and A, so as to react selectively each sample.
Also, the output on recorder 88 may be appropriately identified.

Claims (62)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. Analysis apparatus, which comprises: means for flowing reaction mixtures, in turn, along a conduit and on a discrete basis, each of said reaction mixtures comprising a liquid phase including a fluid sample containing a constituent of interest and a solid phase comprising a first reagent bound to magnetically attractable particulate material, reaction taking place in the said mixture to form a reaction product, at least, on said particulate material; means along a portion of said conduit for magnetically trapping said particulate material in each of said reaction mixtures, so as to hold said solid phase against flow and separate said solid phase from the flowing liquid phase; and, downstream of said trapping means, means for determining said constituent of interest by selective analysis of said separated solid phase and/or said separated liquid phase.
2. Apparatus according to claim 1, which further includes:
means for introducing said particulate material into admixture with each fluid sample flowing along said conduit.
3. Apparatus according to claim 1, wherein said trapping means comprises first magnetic means to provide a magnetic field in said portion of said conduit and substantially transverse of the direction of reaction mixture flow.
4. Apparatus according to claim 1, wherein said trapping means comprises first and second magnetic means to provide spaced magnetic fields in said portion of said conduit, said second magnetic means being downstream with respect to said first magnetic means.
5. Apparatus according to claim 4, which further includes;
means for independently actuating said first and second magnetic means.
6. Apparatus according to claim 1, which further includes:

means for passing wash liquid, at least, along said portion of said conduit intermediate said successive reaction mixtures.
7. Apparatus according to claim 3, which further includes:
means for passing wash liquid, at least, along said portion of said conduit intermediate said successive reaction mixtures, and means for actuating said first magnetic means to hold said particulate material for washing by said wash liquid and, sub-sequently, de-actuating said first magnetic means to release said particulate material into suspension in said wash liquid.
8. Apparatus according to claim 5, which further includes:
means for passing wash liquid, at least, along said portion of said conduit and intermediate said successive reaction mixtures, and wherein said actuating means includes means for actuating said first and second magnetic means concurrently to hold said particulate material for washing by said wash liquid and, subsequently, for selectively de-actuating said first magnetic means to release said particulate material held thereby into suspension in said wash liquid and be carried to said second magnetic means.
9. Apparatus according to claim 4, wherein each of said first and second magnetic means, when actuated, provide magnetic fields substantially transverse of the direction of reaction mixture flow in said conduit.
10. Apparatus according to claim 4, wherein each said first and second magnetic means is electromagnetic.
11. Apparatus according to claim 10, which further includes:
means for degaussing each of said first and second magnetic means.
12. Apparatus according to claim 1, which further includes:
means for successively flowing said reaction mixtures along said conduit, and means for introducing an occluding inert fluid segment intermediate successive reaction mixtures to maintain said successive reaction mixtures discrete.
13. Apparatus according to claim 12, which further includes:
means for introducing additional occluding inert fluid segments into said conduit to sub-divide each of said reaction mixtures.
14. Apparatus according to claim 12, which further includes:
means for providing a wash liquid segment between successive reaction mixtures flowing in said conduit, each of said reaction mixtures being separated from adjacent wash liquid segments by at least an occluding inert fluid segment.
15. Apparatus according to claim 1, which further includes:
means for passing successive fluid samples along said conduit, and means for introducing said particulate material into said conduit on an intermittent basis.
16. Apparatus according to claim 15, which further includes:
a source of said particulate material, and wherein said inter-mittent introducing means includes means for continuously pumping said particulate material from said source and for returning to said source said particulate material not admitted to said conduit.
17. Apparatus according to claim 15, which further includes:
means for introducing buffer solution into said conduit altern-ately with said particulate material so as to maintain the flow along said conduit substantially constant.
18. Apparatus according to claim 3, which further includes:
means upstream of said portion of said conduit for detecting the passage of each of said reaction mixtures along said conduit, and means responsive to said detecting means for actuating said magnetic means to trap said particulate material in each said reaction mixture.
19. Apparatus according to claim 1, which further includes:
means for providing a second reagent in each of said reaction mixtures.

??
20. Apparatus according to claim 1, which further includes:
means for introducing a second reagent into admixture with each said reaction mixture flowing along said conduit.
21. Apparatus according to claim 1, further including, downstream of said trapping means, valving means in said conduit for selectively directing said separated solid phase or said separated liquid phase to said determining means.
22. Apparatus according to claim 1, wherein said determining means includes means for measuring radioactively, color, fluorescence or luminescence.
23. A method of analyzing a plurality of fluid samples for particulate constituents of interest, which comprises the steps of:
(a) forming a reaction mixture of each of said fluid samples, each reaction mixture comprising a liquid phase and a solid phase, said solid phase comprising a first reagent bound to magnetically attractable particulate material and reactive with the particular constituent to be analyzed in each said fluid sample to form a reaction product, at least on said particulate material;
(b) flowing each said reaction mixture in turn and on a discrete basis along a conduit;
(c) magnetically trapping said particulate material in each said reaction mixture during flow along a first portion of said conduit, so as to hold said particulate material and thereby separate said solid phase from said liquid phase; and (d) determining the constituent of interest in each said sample by selective analysis of said separated solid phase and/or said separated liquid phase.
24. A method according to claim 23, further comprising the step of: introducing said solid phase along said conduit into admixture with each said fluid sample.
25. A method according to claim 23, further comprising the step of passing wash liquid along, at least, said first portion of said conduit while trapping said particulate material.
26. A method according to claim 25, further comprising the step of: re-suspending said trapped particulate material into said wash liquid.
27. A method according to claim 26, wherein, said re-suspended particulate material is carried to a second portion of said conduit downstream of said first portion, and further comprising the steps of: magnetically trapping said particulate material at said second portion of said conduit, passing wash liquid along said second portion of said conduit while trapping said part-iculate material, and re-suspending said trapped particulate matter into said wash liquid.
28. A method according to claim 23, further comprising the steps of: releasing said trapped particulate material, and separately collecting said released particulate matter.
29. A method according to claim 23, wherein said particulate material is trapped using at least one or more electromagnetic means, and comprising the further step of: degaussing said electromagnetic means upon release of said trapped particulate material.
30. A method according to claim 23, comprising the further step of: passing said reaction mixtures successively along said conduit, and introducing at least an occluding inert fluid seg-ment intermediate successive reaction mixtures, so as to maintain said successive reaction mixtures discrete.
31. A method according to claim 30, comprising the further step of: introducing additional occluding inert fluid segments into said conduit to split each of said reaction mixtures into two or more segments.
32. A method according to claim 30, comprising the further step of: providing a wash liquid segment between successive reaction mixtures in said conduit, each said reaction mixture being separated from adjacent wash liquid segments by at least an inert fluid segment.
33. A method according to claim 23, comprising the further step of: introducing said particulate material into said conduit on an intermittent basis to merge with said successive fluid samples.
34. A method according to claim 33, comprising the further step of introducing buffer solution into said conduit alternately with said particulate material to maintain flow along said conduit substantially constant.
35. A method according to claim 23, comprising the further step of: providing a second reagent into each said reaction mixture.
36. A method according to claim 35, further including the step of: introducing said second reagent into admixture with each of said fluid samples flowing along the conduit.
37. Apparatus according to claim 1, wherein the fluid samples are human or animal samples.
38. Apparatus according to claim 37, wherein the constituent of interest is an antigen, antibody, or antigen:anti-body complex.
39. Apparatus according to claim 19, wherein said constituent of interest is an antigen, said first reagent is an antibody to said antigen, and said second reagent is an antigen which can bind with the antibody and which carries an identifying label.
40. Apparatus according to claim 19, wherein said constituent of interest is an antibody, said first reagent is an antigen capable of binding with said antibody, and said second reagent is an antibody which is capable of binding with said antigen and which carries an identifying label.
41. Apparatus according to claim 39, wherein the said label is a radioactive atom, a fluorescent group, an enzyme or co-enzyme, or a chemiluminescent material.
42. Apparatus according to claim 19, wherein said second reagent comprises a predetermined amount of substance which reacts with said constituent of interest to form therewith a complex, and wherein said first reagent binds with the said complex or with excess unreacted second reagent.
43. Apparatus according to claim 19, wherein said second reagent carries a radioactive label.
44. Apparatus according to claim 1, wherein said first reagent bound to said particulate material is a virus or an immunoglobulin.
45. Apparatus according to claim 1, wherein said particulate material is of a composite structure.
46. Apparatus according to claim 45, wherein said particulate material comprises a matrix containing magnetically attractable material.
47. Apparatus according to claim 46, wherein said matrix comprises an organic material capable of binding to said first reagent.
48. Apparatus according to claim 1, wherein said particulate material has a specific gravity close to that of said reaction mixture.
49. Apparatus according to claim 48, wherein the specific gravity of said particulate material is substantially in the range of 1.4 to 3.2.
50. Apparatus according to claim 40, wherein the said label is a radioactive atom, a fluorescent group, an enzyme or co-enzyme, or a chemiluminescent material.
51. A method of analyzing a plurality of fluid samples for particular constituents of interest, which comprises the steps of:
(a) forming a reaction mixture of each of said fluid samples, said reaction mixture comprising magnetically attractable particulate material and a reagent reactive with a particular constituent to be analyzed to form a reaction product, at least ??

a portion of said reaction product being bound to said particulate material;

(b) flowing each said reaction mixture in turn and on a discrete basis along a conduit;
(c) magnetically trapping said particulate material in each said reaction mixture along a portion of said conduit, so as to separate said particulate material from said reaction mixture; and (d) determining said constituent of interest by selective analysis of said separated particulate material and/or said separated reaction mixture.
52. A method as defined in claim 51, including the further steps of: passing said fluid samples along said conduit on a successive basis, separating successive fluid samples by at least an inert fluid segment, so as to maintain said fluid samples discrete, and introducing said reagent and said particulate material on an intermittent basis to merge with said fluid samples to form said reaction mixtures.
53. A method as defined in claim 51, comprising the further step of: forming said particulate material to have a specific gravity substantially equal to that of said reaction mixture.
54. A method according to claim 51, comprising the further steps of: passing said reaction mixtures successively along said conduit, and introducing, at least, an occluding inert fluid segment intermediate successive reaction mixtures, so as to maintain said successive reaction mixtures discrete.
55. A method according to claim 51, comprising the further step of: providing a wash liquid segment between said successive reaction mixtures, each of said reaction mixtures being separated from adjacent wash liquid segments by at least an inert fluid segment.
56. A method according to claim 51, comprising the further step of: maintaining said particulate material magnetically trapped during passages of at least a portion of said wash liquid segment along said conduit portion.
57. A method of analyzing a fluid sample for a particular constituent of interest, which comprises the steps of:
(a) forming a reaction mixture of said sample, said reaction mixture comprising magnetically attractable particulate material and a reagent reactive with said particular constituent to be analyzed, a product of said reaction mixture being bound to said particulate material;
(b) forming said particulate material to have a specific gravity so as to tend to be suspended within said reaction mixture, such that separation of said particulate material is retarded;
(c) magnetically separating said particulate material from said reaction mixture following reaction of said sample with said reagent; and (d) determining said constituent of interest by selective analysis of said separated particulate material and/or said separated reaction mixture.
58. A method of immunoassaying a sample, comprising the steps of:
mixing:
(a) a sample defining a liquid phase, and (b) a reagent combined with a magnetically attractable particulate defining a solid phase, forming said solid phase to have a specific gravity so as to tend to be suspended within said liquid phase upon mixing of said phases, such that separation of the two phases is retarded and reactivity of the sample with said reagent is enhanced, magnetically separating said liquid and said solid phases following reaction of said sample with said reagent, and measuring a reaction product of said sample and said reagent in said separated solid and/or said liquid phase.
59. The method of claim 58, comprising the further step of forming said solid phase to have a specific gravity approximately equal to the specific gravity of said liquid phase.
60. The method of claim 58, comprising the further step of forming said solid phase to have a specific gravity approximately equal to 1.4.
61. The method of claim 58, wherein said reagent is an antigen, and comprising the step of combining an antibody with said particulate to define said solid phase.
62. The method of claim 58, wherein said reagent is an antibody, and comprising the further step of combining an antigen with said particulate to define said solid phase.
CA273,631A 1976-03-12 1977-03-10 Immunoassay method utilizing magnetically attractable particles Expired CA1079189A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA330,571A CA1080123A (en) 1976-03-12 1979-06-26 Particulate material for use in the analysis of liquid samples

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10089/76A GB1575805A (en) 1976-03-12 1976-03-12 Automatic diagnostic apparatus

Publications (1)

Publication Number Publication Date
CA1079189A true CA1079189A (en) 1980-06-10

Family

ID=9961275

Family Applications (1)

Application Number Title Priority Date Filing Date
CA273,631A Expired CA1079189A (en) 1976-03-12 1977-03-10 Immunoassay method utilizing magnetically attractable particles

Country Status (16)

Country Link
US (1) US4141687A (en)
JP (2) JPS52141697A (en)
AR (1) AR214993A1 (en)
AU (1) AU508301B2 (en)
BE (1) BE852327A (en)
BR (1) BR7701509A (en)
CA (1) CA1079189A (en)
CH (1) CH619537A5 (en)
DD (1) DD129826A5 (en)
DE (1) DE2710438A1 (en)
FR (1) FR2344019A1 (en)
GB (1) GB1575805A (en)
IT (1) IT1116284B (en)
NL (1) NL7702647A (en)
PL (1) PL111132B1 (en)
SE (1) SE7702731L (en)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2841782A1 (en) * 1977-09-28 1979-04-12 Technicon Instr IMMUNE ANALYZES AND PARTICULATE REAGENT FOR USE IN IMMUNE ANALYZES
AU527144B2 (en) * 1978-02-13 1983-02-17 Technicon Instruments Corportion Magnetically attractable material
US4268268A (en) * 1978-04-21 1981-05-19 Blum Alvin S Method and apparatus for characterization of cells, particles, and liquids
US4264327A (en) * 1978-04-21 1981-04-28 Blum Alvin S Method and apparatus for automatic competitive binding analysis
US4277560A (en) * 1978-10-24 1981-07-07 Technicon Instruments Corporation Enzyme immunoassays using immobilized reagents in a flowing stream
US4230685A (en) * 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4297337A (en) * 1979-04-13 1981-10-27 Corning Glass Works Solid-phase immunoassays using magnetic glass
US4283201A (en) * 1979-11-02 1981-08-11 Phillips Petroleum Company Method and apparatus suitable for repeated, accurate chemical analyses
EP0030087A1 (en) * 1979-11-13 1981-06-10 Technicon Instruments Company Limited Immunoassay method and apparatus and kit for carrying out the method
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
US4454234A (en) * 1981-12-30 1984-06-12 Czerlinski George H Coated magnetizable microparticles, reversible suspensions thereof, and processes relating thereto
JPS59195161A (en) * 1983-04-21 1984-11-06 Fujirebio Inc Magnetic particle and its production
US4695392A (en) * 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4695393A (en) * 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4554088A (en) * 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4628037A (en) * 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4698302A (en) * 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
GB8401368D0 (en) * 1984-01-19 1984-02-22 Amersham Int Plc Assay method
FR2571498B1 (en) * 1984-10-04 1988-04-08 Immunotech Sa METHOD FOR SEPARATING CELLS USING LOW DENSITY ANTIBODIES AND BALLS
EP0180384B1 (en) * 1984-11-01 1991-04-24 TECHNICON INSTRUMENTS CORPORATION(a Delaware corporation) Magnetically responsive reagent carrier and method of preparation
US4684470A (en) * 1985-08-09 1987-08-04 The Dow Chemical Company Apparatus and method for membrane-permeation separations using segmented flow
US4834877A (en) * 1985-08-09 1989-05-30 The Dow Chemical Company Apparatus for membrane-permeation separations using segmented flow
US4666595A (en) * 1985-09-16 1987-05-19 Coulter Electronics, Inc. Apparatus for acoustically removing particles from a magnetic separation matrix
US4661408A (en) * 1986-03-18 1987-04-28 E.I. Du Pont De Nemours And Company Coated chromium dioxide particles
US5137827A (en) * 1986-03-25 1992-08-11 Midwest Research Technologies, Inc. Diagnostic element for electrical detection of a binding reaction
US5219554A (en) * 1986-07-03 1993-06-15 Advanced Magnetics, Inc. Hydrated biodegradable superparamagnetic metal oxides
US5069216A (en) * 1986-07-03 1991-12-03 Advanced Magnetics Inc. Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract
JPS6337230A (en) * 1986-07-31 1988-02-17 Shimadzu Corp Suction and injection of liquid specimen
US5223398A (en) * 1987-03-13 1993-06-29 Coulter Corporation Method for screening cells or formed bodies for enumeration of populations expressing selected characteristics
US5238812A (en) * 1987-03-13 1993-08-24 Coulter Corporation Method and apparatus for rapid mixing of small volumes for enhancing biological reactions
US4895650A (en) * 1988-02-25 1990-01-23 Gen-Probe Incorporated Magnetic separation rack for diagnostic assays
JP2502148B2 (en) * 1989-04-20 1996-05-29 日本電信電話株式会社 Non-separable laser magnetic immunoassay method and measuring apparatus
US5236824A (en) * 1988-04-26 1993-08-17 Nippon Telegraph And Telephone Corporation Laser magnetic immunoassay method and method by a magnetophoresis apparatus therefor
US5145784A (en) * 1988-05-04 1992-09-08 Cambridge Biotech Corporation Double capture assay method employing a capillary flow device
JPH0661357B2 (en) * 1988-07-14 1994-08-17 ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム Intra-barrel catheter
US5536475A (en) * 1988-10-11 1996-07-16 Baxter International Inc. Apparatus for magnetic cell separation
JPH02157655A (en) * 1988-12-09 1990-06-18 Seiko Instr Inc Reaction vessel
CA1339840C (en) * 1988-12-16 1998-04-28 Kenneth Kortright Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics
JPH02307059A (en) * 1989-05-23 1990-12-20 Seiko Instr Inc Reaction vessel
US5164297A (en) * 1990-05-03 1992-11-17 Advanced Magnetics Inc. Solvent mediated relaxation assay system
US5254460A (en) * 1990-05-03 1993-10-19 Advanced Magnetics, Inc. Solvent mediated relaxation assay system
US5541072A (en) * 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US6013532A (en) * 1990-09-26 2000-01-11 Immunivest Corporation Methods for magnetic immobilization and manipulation of cells
US5200084A (en) * 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5128103A (en) * 1990-12-14 1992-07-07 E. I. Du Pont De Nemours And Company Apparatus for automatically processing magnetic solid phase reagents
US5466574A (en) * 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5795470A (en) * 1991-03-25 1998-08-18 Immunivest Corporation Magnetic separation apparatus
US5186827A (en) * 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
FI90552C (en) * 1991-10-09 1994-02-25 Leiras Oy Process for Preparation of Nucleoside Derivatives
US5399497A (en) * 1992-02-26 1995-03-21 Miles, Inc. Capsule chemistry sample liquid analysis system and method
US5627522A (en) * 1992-03-27 1997-05-06 Abbott Laboratories Automated liquid level sensing system
US6190617B1 (en) 1992-03-27 2001-02-20 Abbott Laboratories Sample container segment assembly
US5578494A (en) * 1992-03-27 1996-11-26 Abbott Laboratories Cap actuator for opening and closing a container
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
US5646049A (en) * 1992-03-27 1997-07-08 Abbott Laboratories Scheduling operation of an automated analytical system
US5536471A (en) * 1992-03-27 1996-07-16 Abbott Laboratories Syringe with bubble flushing
US5610069A (en) * 1992-03-27 1997-03-11 Abbott Laboratories Apparatus and method for washing clinical apparatus
US5605665A (en) * 1992-03-27 1997-02-25 Abbott Laboratories Reaction vessel
US5540890A (en) * 1992-03-27 1996-07-30 Abbott Laboratories Capped-closure for a container
US5635364A (en) * 1992-03-27 1997-06-03 Abbott Laboratories Assay verification control for an automated analytical system
EP0632894B1 (en) * 1992-03-27 2000-08-23 Abbott Laboratories Methods for providing homogeneous reagents
US5507410A (en) * 1992-03-27 1996-04-16 Abbott Laboratories Meia cartridge feeder
US5575978A (en) * 1992-03-27 1996-11-19 Abbott Laboratories Sample container segment assembly
US5960160A (en) * 1992-03-27 1999-09-28 Abbott Laboratories Liquid heater assembly with a pair temperature controlled electric heating elements and a coiled tube therebetween
JP3115501B2 (en) * 1994-06-15 2000-12-11 プレシジョン・システム・サイエンス株式会社 Method for controlling desorption of magnetic material using dispenser and various devices processed by this method
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
EP0856359B1 (en) * 1997-02-03 2002-04-24 Hitachi, Ltd. Apparatus for magnetic purification
EP1029244A4 (en) * 1997-10-02 2003-07-23 Aclara Biosciences Inc Capillary assays involving separation of free and bound species
CA2260991C (en) * 1997-11-18 2009-03-24 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
US5973138A (en) 1998-10-30 1999-10-26 Becton Dickinson And Company Method for purification and manipulation of nucleic acids using paramagnetic particles
US6623971B2 (en) * 1999-01-11 2003-09-23 Bayer Corporation Method and apparatus for conducting a stat immunoassay analysis in a capsule chemistry analysis system
US6723237B1 (en) * 1999-01-18 2004-04-20 Precision Systems Science Co., Ltd. Concentration device using magnetic particles and method therefor
US6193892B1 (en) 1999-03-03 2001-02-27 Promega Corporation Magnetic separation assembly and method
US8021848B2 (en) * 2001-09-06 2011-09-20 Straus Holdings Inc. Rapid and sensitive detection of cells and viruses
US20030119057A1 (en) * 2001-12-20 2003-06-26 Board Of Regents Forming and modifying dielectrically-engineered microparticles
AU2003226075B2 (en) * 2002-04-12 2008-09-25 Instrumentation Laboratory Company Immunoassay probe
CN100357737C (en) * 2002-11-12 2007-12-26 松下电器产业株式会社 Specific combination reaction analyzing method, analyzer and used kit
US7601491B2 (en) * 2003-02-06 2009-10-13 Becton, Dickinson And Company Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
US20040157219A1 (en) * 2003-02-06 2004-08-12 Jianrong Lou Chemical treatment of biological samples for nucleic acid extraction and kits therefor
JP2004317420A (en) * 2003-04-18 2004-11-11 Hitachi Software Eng Co Ltd Measuring instrument using capillary
JP3711988B2 (en) * 2003-05-12 2005-11-02 株式会社日立製作所 Fine particle array analysis system, fine particle array kit, and chemical analysis method
US20050239091A1 (en) * 2004-04-23 2005-10-27 Collis Matthew P Extraction of nucleic acids using small diameter magnetically-responsive particles
US8211386B2 (en) 2004-06-08 2012-07-03 Biokit, S.A. Tapered cuvette and method of collecting magnetic particles
WO2006017427A1 (en) * 2004-08-03 2006-02-16 Becton, Dickinson And Company Use of magnetic material to fractionate samples
JP5053089B2 (en) * 2004-08-03 2012-10-17 ベクトン・ディキンソン・アンド・カンパニー Use of magnetic materials for direct isolation of compounds and fractionation of multicomponent samples
US7338804B2 (en) * 2004-11-24 2008-03-04 Siemens Healthcare Diagnostics Inc. Automated clinical analyzer reagent formulation
WO2007038478A2 (en) * 2005-09-26 2007-04-05 Rapid Micro Biosystems, Inc Cassette containing growth medium
US8283185B2 (en) * 2006-10-30 2012-10-09 Stc.Unm Magnetically susceptible particles and apparatuses for mixing the same
EP2171098B1 (en) * 2007-06-29 2018-03-28 Becton, Dickinson and Company Methods for extraction and purification of components of biological samples
CA2738317C (en) 2008-09-24 2020-01-14 Straus Holdings Inc. Imaging analyzer for testing analytes
US8293213B2 (en) * 2009-03-12 2012-10-23 Palo Alto Research Center Incorporated Method and apparatus for thrombus removal using magnetic particles
NZ595982A (en) * 2009-04-22 2013-10-25 Clinical Genomics Pty Ltd Method and apparatus for isolating a target bioentity from a biological sample
JP5865252B2 (en) 2009-11-02 2016-02-17 パルス セラピューティクス インコーポレイテッド Magnetostatic stator system and wireless control method of magnetic rotor
CN107051718A (en) 2011-03-11 2017-08-18 杨贵生 Magnetic-particle remove device and method
MX368123B (en) 2011-11-07 2019-09-19 Rapid Micro Biosystems Inc Cassette for sterility testing.
KR102028225B1 (en) 2012-01-25 2019-10-02 젠셀 바이오시스템즈 리미티드 Biomolecule isolation
CN104364388B (en) 2012-04-16 2017-12-19 快速微型生物系统公司 Cell culture apparatus
US9883878B2 (en) 2012-05-15 2018-02-06 Pulse Therapeutics, Inc. Magnetic-based systems and methods for manipulation of magnetic particles
EP3276350B1 (en) 2012-06-22 2020-08-05 Bio-Rad Laboratories, Inc. Human factor xiii as a normalization control for immunoassays
US8969826B2 (en) 2013-01-03 2015-03-03 Arthur Radomski Flowthrough labyrinth device for use in detection of radiation in fluids and method of using same
RU2015132985A (en) * 2013-01-10 2017-02-15 Вантикс Холдингз Лимитед ELECTROCHEMICAL DETECTION SYSTEM AIR RINSING
EP2989463B1 (en) 2013-04-26 2018-11-21 Bio-Rad Laboratories, Inc. Multiplex hepatitis b assay
CA2923817C (en) 2013-09-09 2021-12-28 Lab-On-A-Bead Ab Manufacture of magnetic particles
ES2834880T3 (en) 2015-03-10 2021-06-21 Bio Rad Laboratories Combined treponemal and non-treponemal syphilis test
EP3359558B1 (en) 2015-10-06 2023-12-13 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
US10527614B2 (en) 2015-11-09 2020-01-07 Bio-Rad Laboratories, Inc. Assays using avidin and biotin
WO2018046748A1 (en) 2016-09-12 2018-03-15 Roche Diagnostics Gmbh Methods and compositions for purifying double stranded nucleic acids
CN114011479B (en) * 2017-06-06 2023-05-02 西北大学 Cross-interface magnetic separation
US11918315B2 (en) 2018-05-03 2024-03-05 Pulse Therapeutics, Inc. Determination of structure and traversal of occlusions using magnetic particles
US11278915B1 (en) 2018-07-20 2022-03-22 NeoGeneStar LLC Device for capturing and releasing magnetic particles
CN114778868B (en) * 2022-06-13 2022-11-22 深圳市帝迈生物技术有限公司 Cleaning method of blood analyzer and blood analyzer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129842C (en) * 1962-09-05
US3700555A (en) * 1970-10-12 1972-10-24 Technicon Instr Method and apparatus for lymphocyte separation from blood
US3925018A (en) * 1973-06-08 1975-12-09 Technicon Instr Method and apparatus for quantitative analysis utilizing particulate reagent material
US3933997A (en) * 1974-03-01 1976-01-20 Corning Glass Works Solid phase radioimmunoassay of digoxin

Also Published As

Publication number Publication date
JPS618388B2 (en) 1986-03-13
GB1575805A (en) 1980-10-01
US4141687A (en) 1979-02-27
AR214993A1 (en) 1979-08-31
NL7702647A (en) 1977-09-14
FR2344019A1 (en) 1977-10-07
AU2307277A (en) 1978-09-14
SE7702731L (en) 1977-09-13
IT1116284B (en) 1986-02-10
BE852327A (en) 1977-09-12
FR2344019B1 (en) 1982-04-02
DD129826A5 (en) 1978-02-08
DE2710438A1 (en) 1977-11-03
PL111132B1 (en) 1980-08-30
JPS52141697A (en) 1977-11-26
AU508301B2 (en) 1980-03-13
CH619537A5 (en) 1980-09-30
JPS6250784B2 (en) 1987-10-27
JPS60122374A (en) 1985-06-29
BR7701509A (en) 1978-01-03

Similar Documents

Publication Publication Date Title
CA1079189A (en) Immunoassay method utilizing magnetically attractable particles
US5736413A (en) Immunodiagnostic reagent for carrying out a multi-stage immunoassay of at least one biological substance in a plurality of biological samples
EP0233939B1 (en) Methods and devices for separating, mixing, and detecting components in specific binding assays
EP0358948B1 (en) Method for automatically processing magnetic solid phase reagents
CA2087037C (en) Apparatus and methods for magnetic separation
US5770461A (en) Method and apparatus for separation of solid supports and liquid phase
FI106225B (en) Method and magnetic apparatus for solid phase immunological analysis
US5993740A (en) Immunoassay method and analyzer using magnetic particles
US7354773B2 (en) Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry
JP2005528584A (en) Manipulation of flow-controlled magnetic particles
EP0030087A1 (en) Immunoassay method and apparatus and kit for carrying out the method
EP0690987A4 (en) Immunoassay for determination of cells
US4865997A (en) Assay for ligands by separating bound and free tracer from sample
EP2799871A1 (en) Sample analysis device and sample analysis method
US4239494A (en) Phase separator for continuous-flow analytical systems
Forrest Development and application of a fully automated continuous flow radioimmunoassay system
US4251360A (en) Method and apparatus for the detection of a specific binding protein
JPH05504828A (en) Capillary flow device and dual capture assay method
CA1080123A (en) Particulate material for use in the analysis of liquid samples
Rogers et al. Automation of Radioimmunoassay
Wide Principles, technical difficulties and developments of radioimmunoassay procedures
JPH0665989B2 (en) Immunological analysis method
Clements Filter element in analysis apparatus
PQP Q1 PQ₂R

Legal Events

Date Code Title Description
MKEX Expiry